Upgrade to SI Premium - Free Trial

Haemonetics (HAE) PT Raised to $59 at Jefferies; Reiterates Buy

November 8, 2017 9:08 AM
Jefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles